VTRS — Viatris

Median target
$20
calls from the last 12 months
Implied return
+5.7%
median target vs. price
Coverage
10 analysts · 12 calls
updated in the last 12 months
Consensus
6/3/1+5 net
Buy / Hold / Sell

Which analysts are behind VTRS's consensus?

See every current rating, price target and the analysts' track records for Viatris — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 10 analysts with calls on VTRS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

VTRS elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2025-12-17ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$1,001 - $15,000
2025-11-18CongressGilbert CisnerosCA-CA39Purchasesince trade +82.9%, vs market +68.0%$1K–$15K
2025-08-04ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$1,001 - $150,008
2025-04-08CongressRob BresnahanPA-PA08Salesince trade +173.1%, vs market -119.4%$1K–$15K
2025-04-04ExecutiveTrump, Donald JPresidentPurchaseVIATRIS INC$15,001 - $500,004
2025-03-31CongressGilbert CisnerosCA-CA39Salesince trade +130.7%, vs market -94.3%$1K–$15K
2025-03-10ExecutiveTrump, Donald JPresidentSaleVIATRIS INC$1,001 - $150,003
2025-02-25CongressRob BresnahanPA-PA08Purchasesince trade +77.3%, vs market +48.5%$1K–$15K
2023-04-10CongressDaniel GoldmanNY-NY10Salesince trade +123.1%, vs market -31.7%$1K–$15K
2023-03-06CongressDaniel GoldmanNY-NY10Salesince trade +104.6%, vs market -10.1%$1K–$15K

More: congressional trades on VTRS · insider activity · executive branch · trending